[Schulungsangebot korreliert mit stärkerer Verbesserung und höherer Adhärenz bei Psoriasis-Patienten, die auf Ixekizumab ansprechen]

J Dtsch Dermatol Ges. 2023 Aug;21(8):900-903. doi: 10.1111/ddg.15121_g.

[Article in German]

Kun Hu^{1

2

3}, Minxue Shen^{1

2

3

4}, Mi Zhang^{1

2

3}, Yehong Kuang^{1

2

3}

¹ Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.
² National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.
³ Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China.
⁴ Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, China.

No abstract available

Publication types